Professionnals
area
General
public access

News

Voir

Cancer immunotherapy: no prior antibiotic treatment

Gut dysbiosis caused by the prior use of broad-spectrum antibiotics could impact the efficacy of cancer immunotherapy, in turn leading to a decrease in overall patient survival.   Immune checkpoint inhibitor (ICI) therapy is a form of immunotherapy that provides a new therapeutic option a...
Voir

Key role of tumor bacteria in pancreatic cancer

The composition of pancreatic tumor microbiome, which is impacted by the gut microbiota, could modulate the patient’s immune response and the growth of adenocarcinoma. Could this discovery rekindle the interest in fecal transplants?   Pancreatic ductal adenocarcinoma (PDAC) is a dreaded c...
Voir

Gut microbiota is involved in lung cancer

A team of international researchers recently brought to light the role of gut dysbiosis in lung cancer and identified two bacterial genera which could be used as biomarkers of the disease and its progression.   Although the role of the pulmonary microbiota in the pathogenesis of lung canc...
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. >

Pages

Publications

Medias